FV vector-based gene therapy (Seattle Children's Hospital)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFV vector-based gene therapy (Seattle Children's Hospital)
Drug Alias Namefoamy virus vector-based gene therapy (Seattle Children's Hospital)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSevere Combined Immunodeficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSeattle Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeattle Children'S Hospital
Active IndicationsN/A
Inactive IndicationsSevere Combined Immunodeficiency

Other Information

ATC CodeN/A
Related LinksN/A